Before antibiotics, strep infections were treated with a combination of home remedies, caustic topical applications, surgical removal of the tonsils, and experimental serum therapies. None of these approaches were reliably effective, and strep was a genuinely dangerous infection. In the 1920s, complications from strep, particularly rheumatic fever and rheumatic heart disease, were the leading cause of death among children and young adults aged 5 to 20 in the United States.
Gargles, Caustic Pastes, and Victorian Remedies
For most of the 19th century, doctors treated sore throats and tonsil infections with whatever they had on hand. Silver nitrate was applied directly to inflamed tissue. Nebulized sulfuric acid was inhaled as a “stimulant.” A concoction called “London paste,” made from caustic chemicals, was smeared onto swollen tonsils to shrink them without surgery. Zinc chloride “darts” were plunged into infected tissue. Patients gargled with solutions of various astringents and antiseptics.
At home, families relied on herbal teas, warm salt water gargles, poultices wrapped around the throat, and bed rest. These measures could soothe symptoms but did nothing to fight the underlying bacterial infection. A child with a strep throat infection in 1890 either recovered on their own or didn’t, and the consequences of not recovering could be severe.
What Happened When Strep Went Untreated
The real danger of strep wasn’t always the throat infection itself. The body’s immune response to the bacteria could trigger rheumatic fever days or weeks later, causing joint pain, skin rashes, and, most critically, permanent damage to the heart valves. Rheumatic heart disease became one of the most common cardiac conditions in young people. By the early 1900s, roughly 37% of all urban deaths were caused by infectious diseases, and strep-related complications accounted for a significant share of those.
If strep bacteria entered the bloodstream, the result was often fatal. More than 75% of people who developed blood infections from strep died. Puerperal sepsis, a strep infection that struck women after childbirth, killed mothers at a rate of 175 per 100,000 births in England before 1935. Scarlet fever, caused by toxin-producing strains of strep, swept through communities in devastating outbreaks, hitting children especially hard.
Tonsillectomy as Prevention
With no drug that could kill the bacteria, surgeons turned to a more drastic option: removing the tonsils entirely. The logic was straightforward. If the tonsils were a recurring site of strep infection, taking them out might prevent future episodes and the dangerous complications that followed. Tonsillectomy became one of the most commonly performed surgeries in the United States during the first half of the 20th century. By 1949, American surgeons performed 1.4 million tonsillectomies in a single year.
The procedure was done far more aggressively and broadly than it is today. Children with even mild recurrent sore throats were sent to the operating table. It reduced the frequency of tonsil infections for many patients, but it carried its own surgical risks and did nothing to protect against strep infections at other sites in the body.
Serum Therapy in the 1920s
In the 1920s, researchers began experimenting with antitoxin serums for scarlet fever. The idea was to collect blood from patients who had recovered from scarlet fever, isolate the antibodies their immune systems had produced, and inject those antibodies into sick patients. Horse serum containing strep antitoxins was also developed.
The results were inconsistent. Researchers at the time discovered that the strep bacterium produced multiple different toxins, and a serum made from one patient’s recovery might not neutralize the particular toxin strain infecting another patient. A serum that worked beautifully for one child with scarlet fever could fail completely for the next. Scientists proposed using “polyvalent” serums, blending antibodies from multiple sources, but the approach never became reliable enough to serve as a standard treatment. Serum therapy helped some patients, but it was expensive, unpredictable, and couldn’t be scaled to meet the need.
Sulfa Drugs Changed Everything
The first real breakthrough came not from penicillin but from a red industrial dye. In 1932, a German pathologist named Gerhard Domagk discovered that a dye called prontosil rubrum was remarkably effective at protecting mice infected with the strep bacterium. By 1935, he published results showing it worked in animals, and German physicians confirmed it worked in humans too.
Prontosil belonged to a class of chemicals called sulfonamides, and its impact was immediate and dramatic. Sulfa drugs reduced scarlet fever mortality by 52 to 65% between 1937 and 1943. The death rate from puerperal sepsis in England dropped from 175 to 80 per 100,000 births within just two years of sulfa drugs becoming available, saving more than a thousand mothers’ lives in England alone. Pneumonia deaths fell by 17 to 32%.
Sulfa drugs were the first medications that could actually kill bacteria inside the human body. They weren’t perfect. They caused side effects, didn’t work against all strains, and some patients had allergic reactions. But for the first time in history, a doctor facing a patient with a life-threatening strep infection had something real to offer.
Penicillin and the Modern Era
Alexander Fleming noticed penicillin’s bacteria-killing properties in 1928, when mould spores contaminated a petri dish in his London laboratory and dissolved the surrounding bacterial colonies. He identified the mould as a Penicillium species and found that the substance it produced was effective against all the major gram-positive bacteria, including the ones responsible for scarlet fever, pneumonia, meningitis, and diphtheria. He published his findings in 1929.
The scientific community largely ignored him. It took more than a decade before two other researchers, Howard Florey and Ernst Chain, figured out how to purify and mass-produce penicillin in 1940. Large-scale production ramped up during World War II, and by the mid-1940s, penicillin was available for civilian use. It proved even more effective than sulfa drugs against strep, with fewer side effects, and quickly became the standard treatment.
The shift was stark. Rheumatic fever, which had been the leading killer of American children in the 1920s, dropped dramatically once penicillin made it possible to treat strep throat before complications developed. The combination of improved living conditions, better nutrition, sulfa drugs, and then penicillin brought infectious disease deaths from 37% of all urban deaths in 1900 down to just 6% by 1948.
Why the Pre-Antibiotic Era Matters
For most of human history, a strep throat infection was a roll of the dice. You gargled, you rested, you hoped your body fought it off, and you watched for the signs of something worse. Doctors had tools, but those tools were largely ineffective against the bacteria itself. The progression from caustic pastes to serum therapy to sulfa drugs to penicillin happened within roughly 20 years, transforming strep from a potential death sentence into something curable with a short course of pills. That speed of change is part of why antibiotic resistance today alarms public health experts so much: the world before effective antibiotics is not ancient history, and the diseases that thrived in it haven’t gone anywhere.